Peptide Surge Fuels Unregulated “Gray Market” Products
Public interest in injectable peptides has surged in recent years, driven in part by the popularity of GLP-1 receptor agonists such as Ozempic. More recently, interest has extended to a broader range of peptide compounds marketed for purposes like muscle growth, recovery, anti-aging and the management of various health conditions. This has given rise to […]